US Stock MarketDetailed Quotes
BCRX BioCryst Pharmaceuticals
- 8.010
- -0.360-4.30%
Close Oct 31 16:00 ET
- 8.140
- +0.130+1.62%
Post 17:30 ET
1.66BMarket Cap-10972P/E (TTM)
8.380High7.990Low1.96MVolume8.310Open8.370Pre Close15.96MTurnover1.02%Turnover RatioLossP/E (Static)206.89MShares8.88052wk High-3.48P/B1.54BFloat Cap4.03052wk Low--Dividend TTM192.41MShs Float37.250Historical High--Div YieldTTM4.66%Amplitude0.600Historical Low8.129Avg Price1Lot Size
About BioCryst Pharmaceuticals Company
BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.
Company Profile
SymbolBCRX
Company NameBioCryst Pharmaceuticals
Listing DateMar 3, 1994
Issue Price6.50
Founded1986
CEOMr. Jon P. Stonehouse
MarketNASDAQ
Employees536
Fiscal Year Ends12-31
Address4505 Emperor Boulevard,Suite 200
CityDurham
ProvinceNorth Carolina
CountryUnited States of America
Zip Code27703-8457
Phone1-919-859-1302
Websitehttp://www.biocryst.com
Company Executives
- Name
- Position
- Salary
- Jon P. Stonehouse
- Director, President and Chief Executive Officer
- 4.78M
- Charles K. Gayer
- Chief Commercial Officer
- 1.74M
- Dr. Helen M. Thackray, M.D.
- Chief Research and Development Officer
- 2.39M
- Anthony Doyle
- Chief Financial Officer, Treasurer and Interim Principal Accounting Officer
- 1.79M
- Alane Barnes
- Chief Legal Officer and Corporate Secretary
- 1.93M
- Dr. Nancy J. Hutson, PhD
- Chairman of the Board
- 470.30K
- Theresa M. Heggie
- Independent Director
- 433.57K
- Dr. Steven Galson, M.D.
- Independent Director
- 424.40K
- Vincent J. Milano
- Independent Director
- 434.82K
- Alan G. Levin
- Independent Director
- 434.54K
- Dr. Amy McKee
- Independent Director
- 422.32K
- Machelle Sanders
- Independent Director
- 423.15K
- Stephen J. Aselage
- Independent Director
- 446.90K
- George B. Abercrombie
- Independent Director
- 432.74K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data